HomeNewsBusinessEconomyQ2 GDP expands on pent-up demand; Omicron, services sector key to growth in coming quarters

Q2 GDP expands on pent-up demand; Omicron, services sector key to growth in coming quarters

As India’s GDP grows 8.4% in Q2FY22, the new COVID variant emerges as a threat. Analysts say RBI may start monetary tightening soon and consumption will likely remain subdued

December 01, 2021 / 15:10 IST
Story continues below Advertisement
Representative Image: Shutterstock
Representative Image: Shutterstock

India’s gross domestic product (GDP) at constant prices grew at 8.4 percent in July-September this year, just about covering up the loss in output due to COVID-19 in the last two years, and well below the 20.1 percent mark seen in the previous quarter.

GDP had contracted by 7.4 percent in the corresponding quarter of the previous fiscal. The good news is that most sectors, except trade, transport, hotels and communications, performed well, even if on a low base.

Story continues below Advertisement

Pent-up demand, after the deadly second wave of the pandemic, had swept the country in Q1, and the absence of nationwide lockdowns helped the economic engines to fire up as infections subsided. Some analysts are predicting 5-5.5 percent growth for the remaining six months of the fiscal year, so that the annual GDP growth may reach close to the 9 percent mark.

There are some important takeaways from the latest GDP print. Analysts believe the RBI may begin monetary tightening; the new COVID-19 variant, Omicron, will likely determine the trajectory of economic growth in the coming quarters and consumption will likely remain subdued.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show